Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers

BACKGROUND: In patients with type 2 diabetes (T2D) sodium-glucose cotransporter 2 (SGLT-2) inhibitors improve glycaemic control as well as cardiovascular and renal outcomes. Their effects on l-arginine (Arg) related risk markers asymmetric and symmetric dimethylarginine (ADMA and SDMA) and the prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Gessner, Arne, Gemeinhardt, Anna, Bosch, Agnes, Kannenkeril, Dennis, Staerk, Christian, Mayr, Andreas, Fromm, Martin F., Schmieder, Roland E., Maas, Renke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740418/
https://www.ncbi.nlm.nih.gov/pubmed/34991562
http://dx.doi.org/10.1186/s12933-021-01436-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740418/
https://www.ncbi.nlm.nih.gov/pubmed/34991562
http://dx.doi.org/10.1186/s12933-021-01436-x

Ejemplares similares